Journal article

First experience of SARS-CoV-2 infections in solid organ transplant recipients in the Swiss Transplant Cohort Study.

  • Tschopp J Infectious Diseases Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • L'Huillier AG Pediatric Infectious Diseases Unit, University Hospitals of Geneva and Faculty of Medicine, Genève, Switzerland.
  • Mombelli M Infectious Diseases Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Mueller NJ Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zürich, Switzerland.
  • Khanna N Infectious Diseases & Hospital Epidemiology, University Hospital Basel, Basel, Switzerland.
  • Garzoni C Clinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, Lugano, Switzerland.
  • Meloni D Clinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, Lugano, Switzerland.
  • Papadimitriou-Olivgeris M Infectious Diseases Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Neofytos D Transplant Infectious Diseases Unit, University Hospitals of Geneva and Faculty of Medicine, Genève, Switzerland.
  • Hirsch HH Infectious Diseases & Hospital Epidemiology, University Hospital Basel, Basel, Switzerland.
  • Schuurmans MM Pulmonology, University Hospital Zurich, Zürich, Switzerland.
  • Müller T Nephrology clinic, University Hospital Zurich, Zürich, Switzerland.
  • Berney T Service of Transplantation, University Hospitals of Geneva and Faculty of Medicine, Genève, Switzerland.
  • Steiger J Department for Transplantation Immunology and Nephrology, Basel, Switzerland.
  • Pascual M Transplantation Center, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Manuel O Infectious Diseases Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • van Delden C Transplant Infectious Diseases Unit, University Hospitals of Geneva and Faculty of Medicine, Genève, Switzerland.
Show more…
  • 2020-05-16
Published in:
  • American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. - 2020
English Immunocompromised patients may be at increased risk for complications of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, comprehensive data of SARS-CoV-2 infection in solid organ transplant (SOT) recipients are still lacking. We performed a multicenter nationwide observational study within the Swiss Transplant Cohort Study (STCS) to describe the epidemiology, clinical presentation, treatment and outcomes of the first microbiologically documented SARS-CoV-2 infection among SOT recipients. Overall, 21 patients were included with a median age of 56 years (10 kidney, 5 liver, 1 pancreas, 1 lung, 1 heart and 3 combined transplantations). The most common presenting symptoms were fever (76%), dry cough (57%), nausea (33%), and diarrhea (33%). Ninety-five percent and 24% of patients required hospital and ICU admission, respectively, and 19% were intubated. After a median of 33 days of follow-up, 16 patients were discharged, 3 were still hospitalized and 2 patients died. These data suggest that clinical manifestations of SARS-CoV-2 infection in middle-aged SOT recipients appear to be similar to the general population without an apparent higher rate of complications. These results need to be confirmed in larger cohorts.
Language
  • English
Open access status
bronze
Identifiers
Persistent URL
https://sonar.ch/global/documents/82309
Statistics

Document views: 54 File downloads:
  • Full-text: 0